3rd BIC webinar delivered successfully, recording now available!

Third and final BIC project webinar successfully delivered! More than 60 participants attended the second BIC webinar on “How to Commercialise your Biomarker Discovery” on September 22, 2020.

In this final webinar Valerie Daussin Laurent, the project leader of the BIC consortium, introduced the viewer to the BIC tools, in particular the BIC Guide, which is a web-based tool that supports academic researchers and SMEs when developing an in-vitro diagnostic biomarker invention to a commercial product.

The BIC Consortium is proud to present the results of the BIC project, a set of support tools for researchers, technology transfer offices and SMEs for a better and more successful commercialisation of biomarkers inventions. BIC tools conduct and guide the user through the discovery and innovative process, integrating not only technical and clinical task but also commercial and regulatory considerations.

The tools are available at: bicguide.biomarker.nu

With this final webinar we conclude our webinar series on how to commercialize your biomarker discovery. The series has been very successful with participants attending from all over the world. Attendees ranged from senior researchers and PhD students to managing directors, R&D directors and business development managers of SMEs and large companies.

Webinar topic:

Launching the Support Tool for Biomarker Commercialization (presentation available for download)

Valerie Daussin Laurent, Team Leader Business Development, Aalborg University Hospital, Project Leader BIC consortium

Moderator:Teppo Laaksonen, Network Manager, Turku Science Park Ltd

Eesti Inimesegeneetika Ühingu aastakonverentsil 19.-20. novembril Haapsalus on uudsena kavas startup-ettevõtete sessioon

Eesti Inimesegeneetika Ühingu aastakonverentsil 19.-20. novembril Haapsalus on uudsena kavas startup-ettevõtete sessioon!

Uudisena plaanitakse programmis startup-ettevõtete sessiooni eesmärgiga tutvustada laiemalt oma ideid ja tegevust tervisevaldkonna, geneetika, geneetiliste ja molekulaardiagnostiliste uuringutega seotud uute toodete ning teenuste turuletoomisel. Saabunud sooviavalduste alusel valib ühingu juhatus viis kuni kuus ettevõtet, millised saavad igaüks 10 minuti jooksul suulises ettekandes võimaluse ettevõtet tutvustada. Startuppide sessioonil osalemiseks ootame lühikest motivatsioonikirja ühingu aadressil .
Avalduse esitamise tähtaeg on 10. oktoober.
Tagasiside osalemisvõimaluse kohta edastatakse 15. oktoobril.

Ühingupoolselt on eeldus ettevõttest vähemalt ühe esindaja registreerumine üldistel tingimustel.

Registreerumiseks klikake SIIA

COVID-19 viiruse tõttu jälgime ka meie tähelepanelikult nii haigestumust kui meile etteseatud reegleid. Sestap otsustas ühingu juhatus, et kuulutame konverentsile eelregistreerumise välja, kuid arveid konverentsil osalemise eest hakkame saatma alles peale 16. oktoobrit – nii saame konverentsi korraldusega edasi minna, kuid samas oleme valmis ka vajadusel, meist mittetulenevail põhjusil, konverentsi edasi lükkama.

Nii Tartust kui Tallinnast on osalejaile bussitransport Haapsallu ja tagasi. Haapsalus on eelbroneeritud hotellid Baltic Hotel Promenaadi, Spa hotell Laine, Kongo Hotell ja Päeva Villa.

Eesti Inimesegeneetika Ühing koondab geneetika, genoomika, geenitehnoloogia ja nende siduserialade teadlasi, eksperte, ettevõtjaid, meedikuid, tudengeid jne. Iga-aastane ühingu konverents on selle kogukonna kõige olulisem teadusfoorum Eestis. Konverentsi aastatepikkune edu on tinginud selle laiapõhjaline kaasav programm ja eestikeelne formaat. Teretulnud on kõik, kel on geneetika valdkonnaga ametialane kokkupuude või lihtsalt huvi geneetika vastu.

Second BIC Webinar successfully delivered!

Second BIC Webinar successfully delivered! More than 70 participants attended the second BIC webinar on “How to Commercialise your Biomarker Discovery” on August 27, 2020.

This webinar went into more detail about the Biomarker Commercialization project with the focus on European IVD Regulation with a speaker from the Finnish Medicines Agency FIMEA.

The webinar dived into the regulatory requirements for biomarker development and commercialization, an important know-how for any research group, SME or TTO working with biomarker development.

The IVD regulation is also covered in detail in the Biomarker Commercialization (BIC) toolset, designed to support, step-by-step, both academic researchers and SMEs when developing a biomarker-based invention to a commercial product. The BIC toolset includes a Biomarker Commercialization Guide, which covers technical, clinical, commercial and regulatory aspects, a Best Practices Handbook based on experiences from TTOs in the field, and a review tool for TTOs and a Guide for Regulatory Process. The toolset has been created in the BIC project funded by Interreg Baltic Sea Region Programme, and it will be available for free in summer 2020. 

 Webinar programme:

  • Introduction to European IVD regulation – requirements for biomarker product development and commercialization (Nelli Karhu, Finnish Medicines Agency FIMEA)
  • Q&A  
  • Moderator: Teppo Laaksonen, Network Manager, Turku Science Park Ltd

We are happy to announce that the Best Practices and Pitfalls in Commercializing IVD-Applicable Biomarkers Handbook is now available from biomarker.nu webpage.

Download the ebook here or learn more about the Handbook at the BIC homepage HERE.

Join EIT Health online Mobility and Active Ageing Summer School

The Summer School in Mobility and Active Ageing aims to train professionals to design, develop, and implement support, or health and functional independence promotion solutions for persons with reduced mobility or at risk of mobility reduction, when carrying out their daily activities.

The curriculum is designed to provide the learners with skills viewing the promotion of Mobility and Active Ageing, considering different conditions related with health, disability, and ageing, through solutions based on policies, services, or products.

The online course is organized in 8 modules (70 hours), divided into theoretical sessions (with tutorial) and practical sessions / challenges (with mentoring).

The course aims to train learners from different professional fields:

  • To screen for frailty, falls and mobility limitations in older adults and other adults with clinical conditions and to select the best strategies/interventions to prevent Mobility and Active Ageing.
  • To empower learners by preparing them with the knowledge, skills, and values necessary to participate in research-related decision making and to contribute with solutions to social challenges.

Applications to the Summer School will run until 25th June.

The application fee of 150€ includes the online course, the certificate and the e-book in Mobility and Active Ageing (course contents).

The Summer School awards a certificate to students who successfully complete online course provided they do not exceed the maximum number of absences.
The complete course will correspond to 6 ECTS.

Find out more: http://formesp.fmh.ulisboa.pt/summer-school-mobility-active-ageing/en

BIC Webinar on “How to Commercialise your Biomarker Discovery” is now available online!

Yesterday, on June 3, 2020, the first part of the BIC Webinar series was successfully held! 78 participants from all over the world attended the first BIC webinar on “How to Commercialise your Biomarker Discovery”.

 

The webinar focused on the biomarker commercialization process and the biomarker commercialization guide.
The BIC guide covers technical, clinical, commercial and regulatory aspects, and it is designed to support, step-by-step, both academic researchers and SMEs when developing a Biomarker based invention into a commercial product.
Other tools created during the project will be:
-> Best Practices Handbook based on experiences from TTOs in the field
-> Review tool for TTOs
-> Guide for Regulatory Process

Webinar presentations:

Valerie Daussin Laurent is a business developer at Aalborg University Hospital in Denmark. She has 20 years of experience within innovation, patenting and technology transfer. With a background as a legal adviser in Intellectual Property Rights, she assists researchers from the hospital from discovery to the industrial phase. The support includes patenting, fundraising as well as business development and negotiation with the partners. For the last 2 years, she has been project leader for the BIC consortium.

  • “SME experience with BIC Guide”
    Huram Konjen, CEO of Dianox

Huram Konjen is the CEO of Dianox, a biotechnology company developing diagnostics for infectious diseases. Huram has a master’s degree in Digital Innovation and Management and previously worked at Deloitte as a Management Consultant, where he facilitated innovation labs for companies wanting to develop sustainable products.

Moderator: Teppo Laaksonen

Teppo Laaksonen is a Network Manager at HealthTurku cluster, Turku Science Park Ltd. He has 30 years of experience in the diagnostic industry, in large companies and SMEs. His responsibilities included quality systems, regulatory affairs of medical devices, SME funding, development of platform technology, international marketing, sales and cooperation, and has know-how related to IVD markets and trends. In regard to biomarker commercialization he has knowledge on biomarker registration, quality assurance policy, product development, and upscaling of production.

 

*BIC is an Interreg program in the Baltic Sea Region that develops support tools for researchers, technology transfer offices and SMEs for better and more successful commercialisation of biomarkers inventions. The current results of the BIC project is a set of tools that conduct and guide the user through the discovery and innovative process, integrating not only technical and clinical task but also commercial and regulatory considerations.For more information on biomarker commercialization visit the project’s website: biomarker.nu

Neljapäeval, 30.aprill toimus veebiseminar “Bioplastics and circular economy”

Neljapäeval, 30.aprill toimus eelkõige ettevõtjatele suunatud veebiseminar “Bioplastics and circular economy”
Plastikpakenditesse pakendamine aitab säilitada toodete algseid omadusi, aga kuidas seda teha nii, et pakendi keskkonnamõju oleks väiksem? Seminaril sai hea ülevaate erinevate plastpakendi liikide omadustest, kasutusvõimalustest ja keskkonnamõjudest. Räägiti nii plastiku ringmajanduse soodustamisest kui vetikatest toodetud jäigast (Rootsi) ning suhkruroo jääkidest toodetud painduvast (Eesti) plastikust.

Veebiseminari ettekanded olid järgnevad:

  • Dr. M. Kriipsalu (Eesti Maaülikool) annab ülevaate erinevatest plastikutest, nende omadustest ning mõjust keskkonnale. Samuti avab tausta, kuidas mõni plastik soodustab ja teine takistab ringmajandust.
  • Dr. Dr. F. Gröndahl (KTH Royal Institute of Technology, Rootsi) Töötab asutuses, kus toodetakse vetikatest jäiku plastikpakendeid. Räägib tootmisest ning nende toodete iseloomust.
  • T. Paara (Estiko-Plastar AS) Töötab ettevõttes, kus toodetakse bioloogilisel toorainel põhinevat elastset plastikust pakendeid. Ringmajanduse soodustamine.

Vaata veebiseminari järele siin:

EIT Health Community is tackling COVID-19 related crisis with several initiatives

The EIT Health community is working tirelessly in response to the pandemic, harnessing their combined knowledge and the strength of their network to join the fight against the virus.

The EIT Health teams working across 25 countries are also supporting the community in raising awareness of the European Union’s newly launched COVID-19 initiatives such as the Joint Procurement Agreement for purchasing personal protective equipment, respiratory ventilators and items necessary for coronavirus testing and the rescEU stockpile of supplies needed to fight the coronavirus.

Several organisations in the EIT Health community are directly engaged in the crisis response, from the development of critical medical equipment, potential vaccines and treatment to remote monitoring and patient support and donation of emergency supplies. They are posting the latest examples of  innovative solutions being developed and rolled out across the EIT Health network here: https://eithealth.eu/covid-19-community-response/

EIT Health has also launched a new ‘matchmaking’ solution that allows innovators working in COVID-19-related research, product development, or frontline healthcare to share their on the ground needs and solutions. They have already received offers and asks ranging across software design support, home monitoring solutions and decontamination services, and are currently working through them to create the best matches possible.

‘CELIS – Cluster Excellence in Life Sciences’ provides financial support for international exchanges

30 March, Heidelberg. Today the formal kick-off meeting of CELIS project took place on line. CELIS stands for ‘Cluster Exchange in Life Sciences – internationalisation of SMEs’ and is one of the 13 European Strategic Cluster Partnerships for Excellence (ESCP-4X) selected under the last call for proposals of the European Cluster Excellence Programme (COS-CLUSTER-2018-03-02).  

CELIS combines some of the world-class life science ecosystems in Europe: BioRN Life Science Cluster Rhine Neckar (Germany), Smart Hub Flemish-Brabant (Belgium), Biopeople: Denmark’s Life Science Cluster (Denmark) and Tartu Biotechnology Park (Estonia).

The project helps clusters, networks and business and innovation support organisations to maximize opportunities linked to cross-sectoral and inter-regional cooperation and internationalisation. It offers them and their members unique opportunities to expand their   relationships and to enhance public-private partnerships.

“Through the programme, the partnerships will have the opportunity not only to improve their competences and strategies for better serving their cluster members, but also to implement the ClusterXchange pilot scheme, the first edition ever!” says Annalisa Zuccotti (BioRN), coordinator of the project.

ClusterXchange will offer financial support to visiting cluster members for matching with peers from other clusters, to take advantage of growth opportunities emerging from collaboration (e.g. uptake of advanced technologies, development of joint projects, follow-up of a matchmaking event, etc.).

The exchanges will be facilitated by CELIS events, the EventXchange that will take place in the four different regions and focus on digitalisation, clinical useful biomarkers, companion diagnostic, micro and nano-electronics and multi-omics.

In addition the partnership discussed also the project and ClusterXchange programme can accelerate research and development in the fight against the SARS-CoV-2 virus.

We are looking forward to an active participation and fruitful exchanges of our members within and beyond the partnership.

Useful links:

CELIS Project website: https://www.health-axis.eu/celis

COSME Data Hub: https://cosme.easme-web.eu/?mode=7&topics=COS-CLUSTER-2018-03-02

EventXchange (constantly updated): https://www.health-axis.eu/celis-events

EIT Health Accelerator programmes – application deadlines extended

Due to the current pandemic, EIT Health has decided to extend the application submission deadline to Monday, 30 March 2020 at 23:59 CET for the following acceleration programmes:

  • Headstart
    Provides funding and mentorship to accelerate the development and time-to-market of innovative products and services.
  • European Health Catapult 
    Showcases start-ups to investors and awards the best health business concepts in Europe.
  • Bridgehead Global
    Support for mature companies to prepare the ground for international expansion and reach a non-European market.

With these programs, EIT Health and EIT Health InnoStars have 5 ongoing applications till the end of March:

  • InnoStars Awards (27th March 2020)
    Through a competitive programme of funding, mentoring and training, the InnoStars Awards help start-ups to verify the need for their healthcare innovations, attract investors and shorten the time it takes to get their ideas to market.
  • Startups Meet Pharma (30th March 2020)
    An acceleration programme that connects start-ups developing innovative solutions around chronic health conditions to leading European pharma partners.
  • Headstart (30th March 2020)
  • European Health Catapult (30th March 2020)
  • Bridgehead Global (30th March 2020)

EIT Health InfoDay 2020 materjalid

09. märts 2020 toimus SPARK Demokeskuses EIT Health Infopäev, kus tutvustati EIT Health Accelerator programmi ja EIT Health BootCamp võimalusi. Üritus oli mõeldud tervisevaldkonna innovaatoritele, ettevõtjatele, teadlastele, tudengitele ja startuppidele.

⚡️Ettekannete salvestised (ingl. k.):

1. Tamás Békási (EIT Health InnoStars) – Accelerator opportunities for early stage startups:

 

2. Harsha Madapura (EIT Health Scandinavia) – EIT Health Bootcamps – Opportunities to develop into an Entrepreneur

 

⚡️Esitluste slaidid EIT Health InnoStars Accelerator and EIT Health Bootcamp võimaluste kohta:
  1. EIT Health Accelerator portfolio_InnoStars2020
  2. EIT Health Bootcamp presentation slides
EIT Health Bootcamps 2020 – ülevaade ja registreerumislingid : https://www.eithealth-scandinavia.eu/for-new-entrepreneurs/

Ürituse toimumist toetas EIT Health ja Euroopa Regionaalarengu Fond

12 great teams pitching at Tartu BioHackathon 2020

A part of sTARTUp Day 2020, the largest business festival in the Baltic countries, the EIT Health supported BioHackathon brough together over 60 participants, including students and starting and established entrepreneurs in the field of life sciences. The BioHackathon was held at the conference hall of the University of Tartu Library on 29th of January, showcasing many inspiring examples of innovation and health development.

 

The event focused on business development and execution of the ideas through an intensive on-site mentoring program as well as learning about numerous possibilities provided by the EIT Health Programme for students and businesses in different development stages. BioHackathon was hosted by Tartu Biotechnology Park and supported by EIT Health RIS program.

At the beginning of the event Merike Leego, Innovation Manager at EIT Health Scandinavia presented an overview of EIT Health and its new opportunities and programs for students, researchers, entrepreneurs, start-ups, scale-ups and SMEs to support health industry entrepreneurs. Another inspiring presentation was given by Priit Aigro – founder, partner and CEO at SMARTdo Plc | HealBed about healBED growth challenges. HealBED is a startup, elaborating and producing vibroacoustic therapy devices and software. This company has also benefited from two EIT Health programs – EIT Health Smart Ageing Camp to use knowledge and experience of scientists and mentors from EIT partner universities to redevelop product and validate customers and the EIT Health BRIDGEHEAD Programme to facilitate soft-landings for start-ups.

After the presentations it was time to form teams focusing on the ideas in biotechnology (all the colors of the rainbow), medicine, veterinary medicine and life sciences in general.

Teams, full of great ideas and ready to improve their business ideas and products had lots of innovative ideas, for example combining the information elements found in breast milk to make a superfood; personalized health solution that analyzes blood and gives beneficial recommendations; zero waste movement or daily life integrated nutrition tracking.
All the teams were supported through the whole event by experienced mentors in the life sciences-, health-, biotech and entrepreneurship sector: Aivar Pere, Kristina Vizovnitš, Katrin Kaarna, Priit Aigro, Kerti Alev, Erki Ani, Priit Kruus, Triin Laisk, Andre Veskioja, Kadri Haljas, Chris Thompson, Elmo Puidet, Siim Saare and Alo Lilles.

BioHackathon culminated with a pitching competition, where all 12 teams pitched their ideas to the jury. Although it was a tough competition, two teams stood out with their highly innovative ideas, full of potential.  Special congratulations to teams Zeme, who won the the Best Pitch prize and got the opportunity to pitch in the Nordic PitchMatch at sTARTUp Day with an idea for animal health surveillance system with antibiotic shots and to MigRevention, who won the Tartu Biotechnology Park Special Prize and was awarded with 5 hours of consultations from Tartu Biotechnology Park  and was also the winner of BioHackathon 2020 with the prize of 500 euros with the idea to create a digital intervention app that connects the self-help solutions for the headache patient and treatment information for the specialist.

The event that took place during the sTARTUp Day 2020 brought together students, researchers, start-ups, mentors and speakers from all over the world. Participants were satisfied with the event, more specifically with the content of the talks, the knowledge they got from there, big variety of pitches from the medical field and networking with active participants and great mentors.

The main supporters of the event were: EIT Health and  TransGeno, a project that has received funding from the European Union’s Horizon programme.

Kutse seminarile: kas Eesti on hea keskkond tehnoloogiliste lahenduste testimiseks?

Eesti tervisetehnoloogia klaster Connected Health kutsub sind neljapäeval, 20.02  arutelule, kus otsitakse vastust küsimusele, kas Eesti on hea keskkond tehnoloogiliste lahenduste testimiseks nii esmatasandi tervishoius kui ka näiteks haiglates? Koos otsitakse vastuseid järgmistele küsimustele:
  • Millised on barjäärid testimiseks
  • Millised on õiguslikud küsimused digilahenduste katsetamisel
  • Millised peaksid olema toetavad mehhanismid testimiste läbi viimisel?

Ühelt poolt soovivad ettevõtted, et lahenduste katsetamine oleks lihtne, selge ja läbipaistev protsess. Teiselt poolt jälle peab tagama andmete kasutamise privaatsuse ning inimeste/ patsientide  põhiõiguste kaitse. 

Seminar – Tervisetehnoloogiate testkeskkondade arendamine Eestis 

Aeg: 20.02.2020 13:00 – 17:30 (webinari ülekanne 14:00 – 15:30) 

Koht: Tallinna Tervishoiu Kõrgkool, ruumid 122 ja 129.

Sihtgrupp: tervishoiu kõrgkoolid (Tallinn ja Tartu), ülikoolid (TalTech, Tallinna Ülikool, Kunstiülikool, Tartu Ülikool), haiglad, perearstikeskused, Tartu Geenivaramu, testimisest huvitatud ettevõtted, Tehnopolise Tervisemajanduse koda.

Keel: inglise + eesti keel 

Moderaator: SpeakSmart, Marleen Pedjasaar 

Seminari kava:

13.00 toimub ekskursioon Tallinna Tervishoiu Kõrgkooli Simulatsioonikeskusesse. Keskus on tervishoiutöötaja töökeskkonda matkiv õpikeskkond. Juhtimiskeskusega ühendatud simulatsiooninukud võimaldavad harjutada erineva raskusastmega protseduuride tegemist, sünnitus- ja esmaabi andmist ning aitavad õppejõududel anda kohest tagasisidet. Külastust aitab läbi viia TTK.

13.45-14.00 (15min) Kogunemine, kohv

14.00-14.10 (10min) Päeva sissejuhatus (Piret, Marleen)

14.10-14.20 (10min) Ettekanne – “Riigi vaade ja ootused testkeskkondadele”, Priit Tohver, e-teenuste valdkonna ja innovatsiooni nõunik, Sotsiaalministeerium

14.20-14.40 (15+5) Ettekanne – “Haigekassa ootused digilahenduste tõendusele”, Rõõt Palmiste, innovatsiooni osakond, Haigekassa

14.40 – 15:00 (15+5) “Tervishoiutehnoloogia magistrikava kui valideerimise labor digilahendustele – koostöö füüsilise ja virtuaalse maailma vahel”, Priit Kruus,  Taltech,  

15:00 – 15:10 (10min) „Rahvusvahelise testimise kogemus Provahealth raames“,  Kadri Englas, Haapsalu Neuroloogiline Rehabilitatsioonikeskus

15:10 – 15:20 (10min) „Transnational living lab“,  Kaija Villman, Natalia Narits XAMK (South-Eastern Finland University of Applied Sciences)

15.20 – 15:35 (10+5) “Digilahenduse suurhaiglas testimine – õppetunnid tulevikuks Triumf Health näitel”, Kadri Haljas, Triumf Health

15.35-15.45 (10min) Paus

15.45-16.30 (45min) Arutelud laudkondades

16:30 – 17:30 Kerge õhtusöök ja networking

Registreeri ennast siin!

Osalemine tasuta. Üritust toetab Euroopa Regionaalarengu fond.

The StarShip Fellowship Program is coming back for 2020 and the APPLICATIONS ARE NOW OPEN!

Are you interested in accessing a global industry R&D environment?

Do you see your future career closing the gap between industry, R&D and healthcare stakeholders?

Do you want to work in a multidisciplinary Trans-European team and help solve real healthcare market challenges?

Do you want to gain an EIT Health diploma and take part in its alumni network? Do you want to make a real impact in health care innovation?


Then this program is for you!

StarShip is an EIT Health educational initiative in collaboration with leading European academic, and health industry partners. Using a blend of different educational approaches including elements from Stanford Biodesign Concept, StarShip is a unique opportunity for participants to be involved in industry-driven life science innovation, working together with innovators in and outside the companies in highly skilled multidisciplinary teams.

Check the projects and testimonials from previous editions!
Who can participate? 

A StarShip future participant must:

  • Have a strong interest in the health sector with a background in one or more of the following areas:
    • Medicine
    • Life science
    • Engineering (biomedical, mechanical, or other)
    • Economics or business management
    • Public policy
    • Design
  • Hold a Bachelor’s Master’s or PhD degree in one of the above mentioned fields.
  • Be fluent in English, both written and spoken.
  • Be able to dedicate the equivalent of 9 weeks of full-time work, including some fixed one-week education modules, one or two days visits to companies (potentially), and some dedicated time for on-line teleconferences and teamwork – during the course of the program;
  • Have a strong desire to be a change maker in the healthcare innovation space

Participants are eligible from the following countries: Belgium, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Israel, Latvia, Lithuania, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom.

How to participate?

Send your CV and a letter of motivation to by 31st January 2020, 23h59min CET.
A reference letter is not required in the first application phase but it will be requested if the applicant is shortlisted in this selection phase.

In case of questions please contact:

StarShip is powered by:

Business support project successfully invested in the development of Estonian and Latvian entrepreneurship

The EstLat BioBoost project was called to life in order to boost cross-border collaboration in life sciences and biotechnology in Estonia and Latvia.

Despite some difficulties, the project can be considered to be a success.

The primary activities within the project were strong coaching and mentorship and useful trainings. In addition, six thorough Business Labs were organised for the selected Estonian and Latvian enterprises, which formed a group that learned from and supported each other. The beginning of the project focused on the ABC-s of starting and running a business. As the project developed, the topics of the trainings and mentorship went deeper and great care was taken so that the programme would be designed based on the real needs of participating companies with a focus on being able to get first-round private investment. The topics covered included for example: Creation of and work with a Business Roadmap, and then moving towards important questions such as: Why is it important for startups to keep innovating and moving forward, therefore, focusing on gaining new knowledge and improving entrepreneurship skills. Co-operation between startups and large enterprises has also been a topic company owners have shown great interest towards as well as The different aspects of investor-company relationships. The programme was concluded with a pitching contest and networking trip to Helsinki.

The project partners together with personal mentors of enterprises supported the development of enterprises participating in the project within the Business Labs.

Photo 1. November 2019, networking trip to Helsinki

Photo 2.  August 2018, 2-day training in Pärnu

.

Photo 3.  August 2018, 1st Business Lab in Pärnu

As one of the six Business Labs and a Pitching event was organised in parallel and in cooperation with the largest business festival in the Baltics – sTARTUp Day 2019, it helped to gain the project and its activities a wider audience and a greater number of beneficiaries.

Photo 4. January 2019, EstLat pitching event in Tartu at sTARTUp Day 2019

At the end of the project, the most successful enterprises received the opportunity to participate in a networking trip to Finland. The companies visited different health and life science hubs: Terkko HealthHub, Maria 01 and SLUSH offices and also met other life sciences companies operating in Finland. The visit also included discussions regarding the similarities and differences between Finnish, Latvian and Estonian healthtech and biotech ecosystems as well as a meeting and matchmaking event with investors.

Altogether, the project events included more than 300 participants (185 unique participants).

The project was supported by EstLat Interreg Programme and its duration was 1.03.2017-31.12.2019.

       

The application for EIT Health’s Wild Card programme is open!

Every year, Wild Card builds two new ventures that break new ground, push boundaries and troubleshoot some of European healthcare’s greatest challenges.They attract the brightest talents, mentor founders‑to‑be and invest up to €2 million in the two most promising ventures.

Now in its third year, the Wild Card programme selects two challenges that represent a pressing health issue for European citizens.
The two challenge areas Wild Card 2020 is focused on are: 

  • Women’s Health
  • Digital Therapeutics
Wild Card is accepting applications for its 2020 challenges until 9 February 2020 23:59 CET.

Find more information and how you can apply here: https://wildcard.eithealth.eu/about-wild-card/